Nephrotoxic effects of domestic iodixanol injection in old patients with coronary heart disease
CSTR:
Author:
Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective To evaluate the nephrotoxic effects of domestic iodixanol injection in the elderly patients with coronary heart disease (CHD). Methods A multicenter, single blind, randomized controlled clinic trial was prospectively carried out in 5 hospitals in Liaoning Province from July 2013 to March 2014. Eighty-eight patients of 60 to 75 years old with CHD undergoing percutaneous coronary intervention (PCI) were divided into 2 groups: experimental group (domestic iodixanol injection group, n=44) and control group [Visipaque (trade name of iodixanol) group, n=44]. The clinical information including age, gender, body mass index (BMI), serum creatinine (SCr) and blood urea nitrogen (BUN) was recorded before PCI. Their SCr and BUN were determined in 48 h after PCI for renal function in the patients of the 2 groups. Results All of them underwent PCI smoothly, with a successful rate of 100%. There was no significant difference in the age, gender, BMI, SCr and BUN between the 2 groups before PCI (P>0.05). No difference was found in the renal function in the 2 groups before and after PCI (P>0.05). One patient of each group had nausea and vomiting respectively just in the day after operation, and recovered on the next day. None of patient had contrast-induced acute kidney injury or other adverse reactions. Conclusion Domestic iodixanol injection is safe for old patients with CHD underwent PCI.

    Reference
    Related
    Cited by
Get Citation
Related Videos

Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:
  • Revised:
  • Adopted:
  • Online: October 08,2014
  • Published:
Article QR Code